Therefore, during the progression of pancreatic cancer, TLR3 acts as a double-edged sword, serving as part of the immune system’s defense while potentially accelerating the malignant transformation of tumors due to chronic inflammation. This evidence concerns the gene TLR3 and familial pancreatic carcinoma.